Pneumococcal Surface Protein A Is Expressed In Vivo, and Antibodies to PspA Are Effective for Therapy in a Murine Model of Pneumococcal Sepsis

Ítems similars

• Effects of PspA and Antibodies to PspA on Activation and Deposition of Complement on the Pneumococcal Surface
  per: Ren, Bing, et al.
  Publicat: (2004)
• Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae
  per: Briles, David E., et al.
  Publicat: (2000)
• Pneumococcal Diversity: Considerations for New Vaccine Strategies with Emphasis on Pneumococcal Surface Protein A (PspA)
  per: Briles, David E., et al.
  Publicat: (1998)
• Comparison of the PspA Sequence from Streptococcus pneumoniae EF5668 to the Previously Identified PspA Sequence from Strain Rx1 and Ability of PspA from EF5668 To Elicit Protection against Pneumococci of Different Capsular Types
  per: McDaniel, Larry S., et al.
  Publicat: (1998)
• Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  per: Roche, Hazeline, et al.
  Publicat: (2003)